Three-month effects of candesartan cilexetil, an angiotensin II type 1 (AT1) receptor antagonist, on left ventricular mass and hemodynamics in patients with essential hypertension.
- 1 January 1998
- journal article
- clinical trial
- Published by Springer Nature in Cardiovascular Drugs and Therapy
- Vol. 12 (5) , 469-474
- https://doi.org/10.1023/a:1007754100351
Abstract
No abstract availableKeywords
This publication has 0 references indexed in Scilit: